Malaysia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Malaysia

The Malaysian market for other medicaments for therapeutic or prophylactic uses contracted to $X in 2022, reducing by X% against the previous year. Overall, the total consumption indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2020 indices. As a result, consumption reached the peak level of $X. From 2015 to 2022, the growth of the market failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Malaysia

In value terms, production of other medicaments for therapeutic or prophylactic uses reduced to $X in 2022 estimated in export price. Overall, production, however, enjoyed a strong expansion. The pace of growth was the most pronounced in 2014 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2015 to 2022, production of growth failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Malaysia

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after four years of decline. Over the period under review, exports, however, recorded a deep reduction. The most prominent rate of growth was recorded in 2016 when exports increased by X%. The exports peaked at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses declined to $X in 2022. Overall, exports, however, recorded a deep contraction. The pace of growth was the most pronounced in 2013 when exports increased by X% against the previous year. As a result, the exports attained the peak of $X. From 2014 to 2022, the growth of the exports of remained at a somewhat lower figure.

Exports by Country

Brunei Darussalam (X tons) and Singapore (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Malaysia.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Brunei Darussalam (with a CAGR of X%).

In value terms, Singapore ($X) and Brunei Darussalam ($X) constituted the largest markets for other medicaments for therapeutic or prophylactic uses exported from Malaysia worldwide.

Among the main countries of destination, Brunei Darussalam, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, over the period under review.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, shrinking by X% against the previous year. In general, the export price recorded a noticeable decrease. The pace of growth was the most pronounced in 2013 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2014 to 2022, the average export prices remained at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Singapore ($X per ton), while the average price for exports to Brunei Darussalam amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Hong Kong SAR (X%), while the prices for the other major destinations experienced a decline.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Malaysia

In 2022, overseas purchases of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons for the first time since 2019, thus ending a two-year rising trend. Overall, imports, however, continue to indicate a noticeable expansion. The pace of growth was the most pronounced in 2020 when imports increased by X% against the previous year. Imports peaked at X tons in 2021, and then shrank in the following year.

In value terms, imports of other medicaments for therapeutic or prophylactic uses rose notably to $X in 2022. In general, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. Imports peaked at $X in 2013; however, from 2014 to 2022, imports failed to regain momentum.

Imports by Country

India (X tons), China (X tons) and Ireland (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Malaysia, with a combined X% share of total imports.

From 2012 to 2022, the biggest increases were recorded for China (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest other medicaments for therapeutic or prophylactic uses suppliers to Malaysia were India ($X), Ireland ($X) and China ($X), together comprising X% of total imports.

China, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the import price, however, continues to indicate a noticeable descent. The most prominent rate of growth was recorded in 2014 when the average import price increased by X%. Over the period under review, average import prices hit record highs at $X per ton in 2016; however, from 2017 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Ireland ($X per ton), while the price for Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Thailand (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :